NC
TMO icon

NovaPoint Capital’s Thermo Fisher Scientific TMO Stock Holding History

NovaPoint Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$939K Buy
+1,873
New +$899K 0.2% 79
2025
Q4 		– Sell
-2,269
Closed -$1.1M – 134
2025
Q3 		$1.1M Buy
+2,269
New +$1.06M 0.27% 75
2025
Q2 		– Sell
-2,368
Closed -$1.18M – 123
2025
Q1 		$1.18M Sell
2,368
-113
-5% -$61.2K 0.36% 64
2024
Q4 		$1.29M Buy
2,481
+12
+0.5% +$6.6K 0.39% 61
2024
Q3 		$1.53M Buy
2,469
+14
+0.6% +$8.29K 0.47% 58
2024
Q2 		$1.36M Buy
2,455
+17
+0.7% +$9.74K 0.46% 61
2024
Q1 		$1.42M Buy
2,438
+315
+15% +$177K 0.5% 61
2023
Q4 		$1.13M Sell
2,123
-44
-2% -$21.3K 0.42% 61
2023
Q3 		$1.1M Buy
2,167
+15
+0.7% +$7.99K 0.44% 59
2023
Q2 		$1.12M Sell
2,152
-2
-0.1% -$1.08K 0.42% 60
2023
Q1 		$1.24M Buy
2,154
+2
+0.1% +$1.13K 0.51% 54
2022
Q4 		$1.19M Sell
2,152
-32
-1% -$17K 0.52% 52
2022
Q3 		$1.11M Sell
2,184
-103
-5% -$57.6K 0.5% 57
2022
Q2 		$1.24M Sell
2,287
-55
-2% -$30.3K 0.54% 59
2022
Q1 		$1.38M Sell
2,342
-13
-0.6% -$7.47K 0.5% 62
2021
Q4 		$1.57M Buy
2,355
+272
+13% +$170K 0.56% 59
2021
Q3 		$1.19M Buy
2,083
+853
+69% +$468K 0.48% 61
2021
Q2 		$620K Hold
1,230
– – 0.26% 71
2021
Q1 		$561K Buy
1,230
+95
+8% +$45.3K 0.26% 71
2020
Q4 		$529K Buy
1,135
+630
+125% +$295K 0.28% 70
2020
Q3 		$223K Buy
+505
New +$209K 0.14% 93

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NovaPoint Capital's TMO Position: Q2 2026 in Review

NovaPoint Capital opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 1,873 shares worth $939K. The stake represents 0.2% of the portfolio and ranks #79 among its holdings. This is a return to the name: NovaPoint Capital previously reported a position in TMO as recently as Q3 2025.

NovaPoint Capital first reported a position in TMO in Q3 2020 and has held it in 21 quarters since. The position peaked at $1.57M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • NovaPoint Capital held 1,873 shares of Thermo Fisher Scientific worth $939K as of Q2 2026.
  • Thermo Fisher Scientific was a new NovaPoint Capital position in Q2 2026.
  • Thermo Fisher Scientific made up 0.2% of NovaPoint Capital's portfolio in Q2 2026, its #79 holding.
  • NovaPoint Capital first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 21 quarters since.
  • NovaPoint Capital's Thermo Fisher Scientific position peaked at $1.57M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on NovaPoint Capital's 13F filing for Q2 2026, filed 6 Aug 2026.